Replies to post #550953 on NorthWest Biotherapeutics Inc (NWBO)

[branster]

Horse, I believe its just a change in the change of the quality control testing additions as posted earlier.

[Dan88]

It is definitely not the same thing or just an extension of the previously issued authorization (https://www.otcmarkets.com/stock/NWBO/news/Northwest-Biotherapeutics-Announces-Filing-of-Application-for-License-for-Commercial-Manufacturing-at-Sawston-UK-Facilit?id=363861)

December last year's pr: "The second and third licenses were received in December, 2021, from MHRA, and provided authorization for manufacturing cellular therapies for use in clinical trials and compassionate use ("Specials") cases, respectively." 

My guess is it's the real deal, even if not the final issuance, but it signifies all parts have been inspected and all outstanding items have been resolved.

So maybe this is it or a final issuance may be just days away. We will know something definite tomorrow as many investors have contacted the company for clarification.